Omega-3, the fatty acid found in oily fish, could be combined with a commonly used anesthetic to develop drugs to treat breast cancer, according to research published today in the journal Breast Cancer Research. Compounds of Omega-3 fatty acids and propofol reduce the ability of breast cancer cells to develop into malignant tumours, inhibiting cancer cell migration by 50% and significantly reducing their metastatic activity. These new compounds could be developed into a new family of anti-cancer drugs.
Dr Rafat Siddiqui, from the Methodist Research Institute and Indiana University in Indianapolis, and his colleagues studied the effect of two Omega-3 fatty acids, docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), combined with propofol on a breast cancer cell line in vitro. Omega-3 fatty acids such as DHA and EPA have a minimal effect on cancer cells when applied alone. Propofol is a potent anti-oxidant known to inhibit cancer cell migration by only 5-10%.
The results of the study show that propofol and DHA or EPA have a much more significant effect on cancer cells when used in combination, as conjugates, than when used alone. The conjugates inhibit cancer cell adhesion by 15% and 30% respectively, reduce cell migration by 50% and increase apoptosis by 40%.
"These results suggest that the novel propofol-DHA and propofol-EPA conjugates reported here may be useful for the treatment of breast cancer" conclude Siddiqui and colleagues.
Malignant cancer cells are highly invasive cells that have lost the ability to sense cues from their environment. As a result, they start dividing abnormally, migrate and accumulate into malignant tumours, in a process called metastasis, which is potentially life-threatening. The aim of anti-cancer drugs is therefore to prevent the cells from dividing abnormally and from spreading, to kill the cells, or to cause the cells to kill themselves.
Fatty acids are often attached to drugs, becausePage: 1 2 Related medicine news :1
Contact: Juliette Savin
. Omega-3 fatty acids may slow down early Alzheimers in some cases2
. Omega-3 fatty acids may slow cognitive decline in some patients with very mild Alzheimers disease3
. The nude mouse tale: Omega-3 fats save the life of a terminal cancer patient4
. Hormone therapy offers new hope for ovarian cancer patients5
. TB test offers patients quicker and easier diagnosis6
. Panel offers guidelines on skin reactions to new class of cancer drugs7
. Supersize me mice research offers grim warning for Americas fast food consumers8
. New treatment offers relief from chronic back pain9
. Commonly used drug offers promise for premature babies10
. Stenting of abdominal arteries offers welcome relief for intestinal angina11
. Study offers clues to Broken Heart Syndrome